PRESS RELEASE published on 02/07/2024 at 13:00, 2 years 5 months ago Two Labs Launches Sunshine Transparency and Aggregate Spend Offering to Provide Transparency Reporting and Compliance Support to the Pharma Industry Two Labs, an Envision Pharma Company, launches Sunshine Transparency and Aggregate Spend service to help pharmaceutical manufacturers with regulatory compliance and transparency in financial relationships with healthcare professionals and organizations Two Labs Envision Pharma Company Sunshine Transparency Aggregate Spend Pharmaceutical Manufacturers
Published on 07/08/2026 at 08:00, 1 hour 54 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 07/08/2026 at 03:25, 6 hours 29 minutes ago Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp
Published on 07/08/2026 at 01:10, 8 hours 44 minutes ago Galantas Announces Resignation of Chair of the Board
Published on 07/07/2026 at 23:15, 10 hours 39 minutes ago Guanajuato Silver Announces Officer Resignation
Published on 07/07/2026 at 22:15, 11 hours 39 minutes ago Grande Portage Closes C$6 Million Equity Financing
Published on 07/08/2026 at 09:05, 49 minutes ago Voiskey Officially Launches: The First AI Voice Typing App Focused on Expression Intelligence
Published on 07/08/2026 at 09:00, 54 minutes ago Original-Research: Emerald Horizon AG (von NuWays AG): BUY
Published on 07/08/2026 at 09:00, 54 minutes ago Original-Research: The NAGA Group AG (von NuWays AG): BUY
Published on 07/07/2026 at 18:10, 15 hours 44 minutes ago LNA Santé and Euryale join forces to expand hospitalisation at home services across healthcare regions
Published on 07/07/2026 at 18:05, 15 hours 49 minutes ago Covivio - Half-yearly report on the liquidity contract on 30 June 2026
Published on 07/07/2026 at 18:01, 15 hours 53 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 07/07/2026 at 18:00, 15 hours 54 minutes ago Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel